AK Kakkar - Concepedia

Author

AK Kakkar

Also Known As

A K Kakkar, A. K. Kakkar, AK KAKKAR, AK Kakkar, AK. Kakkar, Ajay K Kakkar

Publications

947

Citations

H-Index

Concepts

All Affiliations

AK Kakkar is an author at Thrombosis Research Institute specializing in thrombosis, medicine, and pharmacotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	464
2	Health Sciences	1	1	14
3	Public Health	1	1	389
4	Hepatology	1	1	38
5	Orthopaedics	1	1	12

AK Kakkar

Publications

464

Citations

H-Index

Page 1

	Year	Citations
Prevention and treatment of venous thromboembolism - International Consensus Statement (Guidelines according to scientific evidence) Nicolaides An, Jawed Fareed, AK Kakkar, UCL Discovery (University College London) Pulmonary EmbolismThrombosisInternational Consensus StatementVenous ThrombosisCardiovascular Disease	2006	389
PERIOPERATIVE HEPARIN-THERAPY INHIBITS LATE DEATH FROM METASTATIC CANCER AK Kakkar, R. Hedges, R C N Williamson, International Journal of Oncology Surgical OncologyYear MortalitySurgeryPharmacotherapyThrombosis	1995	38
A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE). M.N. Levine, Ay Lee, Ross Baker, UCL Discovery (University College London) ThrombosisVenous ThrombosisMedicineHematologyAnticoagulant	2002	14
Oral SNAC-heparin vs. enoxaparin for preventing venous thromboembolism following total hip replacement RD Hull, AK Kakkar, V. J. Marder, Journal of Thrombosis and Haemostasis ThrombosisVenous ThrombosisTotal Hip ReplacementOrthopaedicsPharmacotherapy	2003	12
Treatment of acute, symptomatic, proximal deep vein thrombosis with the oral, direct Factor Xa inhibitor rivaroxaban (BAY 59-7939) - the ODIXa-DVT dose-ranging study Giancarlo Agnelli, Alexander Gallus, Samuel Z. Goldhaber, ThrombosisVenous ThrombosisCardiovascular DiseaseOdixa-dvt Dose-ranging StudyBay 59-7939	2006	11

Page 1